Now however Eisais Biogenpartnered drug Leqembi is approved in the US and Lillys donanemab is under Food and Drug Administration review. Roche hasnt fully ended its antiamyloid drug work yet continuing tests of one called crenezumab in people who have an inherited form of Alzheimers